126 related articles for article (PubMed ID: 3240705)
1. Comparative in vitro potencies of nine new macrolides.
Fernandes PB; Hardy DJ
Drugs Exp Clin Res; 1988; 14(7):445-51. PubMed ID: 3240705
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
5. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
[TBL] [Abstract][Full Text] [Related]
8. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of dirithromycin in comparison with other new and established macrolides.
Bauernfeind A
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():39-49. PubMed ID: 8478311
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Meyran M; Joly B; Derlot E; Morel C
Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
[TBL] [Abstract][Full Text] [Related]
11. [Azithromycin: critical points].
Philippon A; Cluzel R; Soussy CJ
Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
[TBL] [Abstract][Full Text] [Related]
12. [New macrolides].
Portier H; Buisson M; Chavanet P
Rev Prat; 1994 Jun; 44(12):1629-34. PubMed ID: 7939238
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
14. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
15. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
Dibb WL; Ragnhildstveit E
NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
[TBL] [Abstract][Full Text] [Related]
17. [Selection of constitutive mutants of gram-positive cocci inducible resistant to macrolides, lincosamides and streptogramins (MLS): comparison of the selective effects of the MLS].
Leclercq R; Bauduret F; Soussy CJ
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):568-72. PubMed ID: 2508040
[TBL] [Abstract][Full Text] [Related]
18. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
Braga PC
J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of isomeric 15-membered azalides.
Alihodzic S; Fajdetic A; Kobrehel G; Lazarevski G; Mutak S; Pavlovic D; Stimac V; Cipcic H; Kramaric MD; Erakovic V; Hasenöhrl A; Marsic N; Schoenfeld W
J Antibiot (Tokyo); 2006 Dec; 59(12):753-69. PubMed ID: 17323642
[TBL] [Abstract][Full Text] [Related]
20. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
